On 12 November 2016
Raymed Labs will hold a meeting of the Board of Directors of the Company on 12 November 2016 to consider and approve the Unaudited Financial Results including Statement of Assets and Liabilities along with the Limited Review Report as provided by the Auditor as per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Quarter ended on September 30, 2016.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content